Transcutaneous electrical acupoint stimulation for children with attention-deficit/hyperactivity disorder: a randomized clinical trial.
Transcutaneous electrical acupoint stimulation for children with attention-deficit/hyperactivity disorder: a randomized clinical trial.
复制标题
DOI:
10.1038/s41398-022-01914-0
复制
发表时间:
2022-04-21
影响因子:
6.8
通讯作者:
Li, Yan
中科院分区:
文献类型:
--
作者:
Zhuo, Lixia;Zhao, Xiaoyan;Zhai, Yifang;Zhao, Boqiang;Tian, Lin;Zhang, Yannan;Wang, Xiaodan;Zhang, Tingyu;Gan, Xinyi;Yang, Cheng;Wang, Weigang;Gao, Wei;Wang, Qiang;Rohde, Luis Augusto;Zhang, Jie;Li, Yan
Little is known about the effects of transcutaneous electrical acupoint stimulation (TEAS) for children with attention-deficit/hyperactivity disorder (ADHD). Here, we carried out a 4 week randomized clinical trial in which patients aged 6–12 years old with an ADHD diagnosis received TEAS or sham TEAS. The primary outcome measure was the investigator-rated Clinical Global Impression-Improvement (CGI-I) score at week 4. Secondary outcomes included changes from baseline to week 4 in the investigator-rated Clinical Global Impression-Severity of Illness (CGI-S) score, the Conners’ Parent/Teacher Rating Scales-Revised: Short Form (CPRS-R: S/CTRS-R: S) score, go/no-go task performance, and functional near-infrared spectroscopy (fNIRS)-based oxygenated hemoglobin level within the prefrontal cortex. At week 4, the CGI-I score indicated improvement in 33.3% of the TEAS group compared with 7.7% of the sham group (P = 0.005). The TEAS group had a greater decrease in the mean CGI-S score (−0.87) than the sham TEAS group (−0.28) (P = 0.003). A greater enhancement in the mean cerebral oxygenated hemoglobin within the prefrontal cortex was found in the TEAS group (0.099 mM mm) compared with the sham TEAS group (0.005 mM mm) (P < 0.001). CPRS-R: S score, CTRS-R: S score, and go/no-go performance exhibited no significant improvement after TEAS treatment. The manipulation-associated adverse events were uncommon in both groups, and events were very mild. Our results show that noninvasive TEAS significantly improved general symptoms and increased prefrontal cortex blood flow within 4 weeks for children with ADHD. Further clinical trials are required to understand the long-term efficacy in a larger clinical sample. This trial was registered on ClinicalTrials.gov (NCT 03917953).
登录
查看更多内容
影响因子:
2.3
作者:
Cubillo, Ana;Halari, Rozmin;Rubia, Katya
通讯作者:
Rubia, Katya
影响因子:
3.6
作者:
Li, Shasha;Yu, Bo;Wang, Xiaotong
通讯作者:
Wang, Xiaotong
影响因子:
2.5
作者:
Hong SS;Cho SH
通讯作者:
Cho SH
影响因子:
2.6
作者:
Byeon, Hyung-sik;Moon, Sang-kwan;Bae, Hyung-sup
通讯作者:
Bae, Hyung-sup
影响因子:
1.1
作者:
Aung, Steven K H
通讯作者:
Aung, Steven K H